Cancer Drugs Cost: Cancer is a very dangerous disease. If it is detected in the beginning, then only its treatment is possible. But treatment also costs a lot of money, which not everyone can afford. Even now, most of the cancer medicines are imported from abroad. Due to importing from abroad, the price of these medicines becomes very high. Understanding this pain, the government has abolished the customs duty on 3 cancer medicines. When any item comes from the other side of the country’s border, the government imposes customs duty on it. With the abolition of customs duty on these three medicines, the price of the medicines is likely to decrease by 15 to 20 percent. However, despite being reduced so much, the price of these medicines will still blow your mind.
Breast cancer medicine becomes cheaper
The names of the three cancer medicines from which the government has removed the custom duty are – Trastuzumab Deruxtecan, Osimertinib and Durvalumab. Out of these, Trastuzumab Deruxtecan is given for the treatment of breast cancer. Apart from this, it is also given for stomach cancer. Cancer cases are increasing rapidly in India. According to statistics, about 14 lakh new cases of cancer are reported every year in India. Of these, the highest number of breast cancer cases come up. Let me tell you that breast cancer medicine trastuzumab deruxtecan Its price is up to 58 thousand rupees. The price of one variant of Biocon’s medicine Canmeb is Rs 54622. Chairman of Medical Oncology at Sir Ganga Ram Hospital Dr. Shyam Agarwal He said that all types of cancer medicines which are imported from abroad are very expensive. If the custom duty is removed from them, then they become very cheap. This step of the government is very commendable.
The cost of medicines for lung cancer and urinary cancer is also low
The name of the second medicine whose price has been reduced by the government is osimertinib (Osimertinib). Lung cancer is treated with Osimertinib. The cost of this medicine is very high. In India, this medicine is available from AstraZeneca company. It has two variants which cost Rs 1.50 lakh. The name of the third medicine is durvalumab (Durvalumab). Durvalumab is used to treat urinary bladder cancer. Apart from this, this drug is also used in lung cancer. Durvalumab is also available in India from AstraZeneca company. This drug also has two variants. Its price ranges from Rs 45500 to Rs 189585.
A huge relief for millions of people
The situation of cancer in India is going to be terrible. The outside world has already started calling India the cancer capital. According to the report, by 2025, the number of cancer patients in India will increase by 15.7 lakhs every year. Here, the highest number of cases of breast cancer, throat cancer and ovarian cancer are reported among women. Whereas, the highest number of cases of lung cancer, mouth cancer and prostate cancer are reported among men. This means that the cost of treatment of lakhs of people will be reduced due to this decision of the government. MD and CEO of Fortis Healthcare Limited Dr. Ashutosh Raghuvanshi It is said that exempting 3 cancer medicines from customs duty is definitely a very big step. Because cancer treatment is a huge financial burden for us. Dr. Ashutosh Raghuvanshi said that reducing customs duty on X-ray tubes and flat panel detectors will provide relief to domestic medical equipment manufacturers. This will reduce its cost. In such a situation, this machine will start being manufactured locally and people will also get new jobs in it.
Also read- Due to deficiency of vitamin B12, nerves become lifeless, body becomes weak, to overcome this, include these things in your diet immediately
Also read this-ALERT: Those who take protein supplements for muscular body should be cautious, many problems like kidney failure, guidelines are coming soon
Tags: health, health tips, Lifestyle
FIRST PUBLISHED : July 23, 2024, 15:56 IST